AZTA
Price
$30.54
Change
+$0.62 (+2.07%)
Updated
Aug 29 closing price
Capitalization
1.4B
77 days until earnings call
BLFS
Price
$25.05
Change
+$0.13 (+0.52%)
Updated
Aug 29 closing price
Capitalization
1.2B
65 days until earnings call
Interact to see
Advertisement

AZTA vs BLFS

Header iconAZTA vs BLFS Comparison
Open Charts AZTA vs BLFSBanner chart's image
Azenta
Price$30.54
Change+$0.62 (+2.07%)
Volume$437.38K
Capitalization1.4B
BioLife Solutions
Price$25.05
Change+$0.13 (+0.52%)
Volume$354.49K
Capitalization1.2B
AZTA vs BLFS Comparison Chart in %
Loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZTA vs. BLFS commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a StrongBuy and BLFS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (AZTA: $30.54 vs. BLFS: $25.05)
Brand notoriety: AZTA and BLFS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AZTA: 54% vs. BLFS: 66%
Market capitalization -- AZTA: $1.4B vs. BLFS: $1.2B
AZTA [@Pharmaceuticals: Other] is valued at $1.4B. BLFS’s [@Pharmaceuticals: Other] market capitalization is $1.2B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.67B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileBLFS’s FA Score has 1 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • BLFS’s FA Score: 1 green, 4 red.
According to our system of comparison, BLFS is a better buy in the long-term than AZTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 7 TA indicator(s) are bullish while BLFS’s TA Score has 6 bullish TA indicator(s).

  • AZTA’s TA Score: 7 bullish, 3 bearish.
  • BLFS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, AZTA is a better buy in the short-term than BLFS.

Price Growth

AZTA (@Pharmaceuticals: Other) experienced а -3.20% price change this week, while BLFS (@Pharmaceuticals: Other) price change was -3.32% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.93%. For the same industry, the average monthly price growth was +6.04%, and the average quarterly price growth was +26.47%.

Reported Earning Dates

AZTA is expected to report earnings on Nov 18, 2025.

BLFS is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.93% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZTA($1.4B) has a higher market cap than BLFS($1.2B). BLFS YTD gains are higher at: -3.505 vs. AZTA (-38.920). BLFS has higher annual earnings (EBITDA): 17.4M vs. AZTA (11.3M). AZTA has more cash in the bank: 319M vs. BLFS (81.8M). BLFS has less debt than AZTA: BLFS (23.8M) vs AZTA (52.6M). AZTA has higher revenues than BLFS: AZTA (669M) vs BLFS (93.5M).
AZTABLFSAZTA / BLFS
Capitalization1.4B1.2B117%
EBITDA11.3M17.4M65%
Gain YTD-38.920-3.5051,110%
P/E RatioN/AN/A-
Revenue669M93.5M716%
Total Cash319M81.8M390%
Total Debt52.6M23.8M221%
FUNDAMENTALS RATINGS
AZTA vs BLFS: Fundamental Ratings
AZTA
BLFS
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
10091
SMR RATING
1..100
9492
PRICE GROWTH RATING
1..100
6448
P/E GROWTH RATING
1..100
5314
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZTA's Valuation (70) in the Electronic Production Equipment industry is in the same range as BLFS (99) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's Profit vs Risk Rating (91) in the Medical Specialties industry is in the same range as AZTA (100) in the Electronic Production Equipment industry. This means that BLFS’s stock grew similarly to AZTA’s over the last 12 months.

BLFS's SMR Rating (92) in the Medical Specialties industry is in the same range as AZTA (94) in the Electronic Production Equipment industry. This means that BLFS’s stock grew similarly to AZTA’s over the last 12 months.

BLFS's Price Growth Rating (48) in the Medical Specialties industry is in the same range as AZTA (64) in the Electronic Production Equipment industry. This means that BLFS’s stock grew similarly to AZTA’s over the last 12 months.

BLFS's P/E Growth Rating (14) in the Medical Specialties industry is somewhat better than the same rating for AZTA (53) in the Electronic Production Equipment industry. This means that BLFS’s stock grew somewhat faster than AZTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTABLFS
RSI
ODDS (%)
Bullish Trend 5 days ago
77%
Bearish Trend 5 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
69%
Bearish Trend 5 days ago
79%
Momentum
ODDS (%)
Bullish Trend 5 days ago
72%
Bullish Trend 5 days ago
76%
MACD
ODDS (%)
Bullish Trend 5 days ago
72%
Bullish Trend 5 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
80%
Bearish Trend 5 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
83%
Bullish Trend 5 days ago
79%
Advances
ODDS (%)
Bullish Trend 12 days ago
71%
Bullish Trend 12 days ago
77%
Declines
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
75%
Bearish Trend 5 days ago
84%
Aroon
ODDS (%)
Bullish Trend 5 days ago
75%
Bullish Trend 5 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DNMDX29.08N/A
+0.01%
Dunham Monthly Distribution N
MWEIX49.32-0.15
-0.30%
MFS Global Equity I
GQEFX34.83-0.16
-0.46%
GMO Quality IV
HAIDX14.71-0.08
-0.54%
Harbor Diversified Intl All Cp Instl
PQDMX16.26-0.12
-0.73%
PGIM Quant Solutions Intl Dev Mkts IdxR6

AZTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with MTD. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then MTD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTA
1D Price
Change %
AZTA100%
+2.07%
MTD - AZTA
65%
Loosely correlated
+1.40%
RVTY - AZTA
64%
Loosely correlated
+0.99%
A - AZTA
64%
Loosely correlated
+0.56%
BRKR - AZTA
59%
Loosely correlated
+1.55%
TMO - AZTA
59%
Loosely correlated
+0.61%
More

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with RGEN. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
+0.52%
RGEN - BLFS
59%
Loosely correlated
+0.12%
A - BLFS
51%
Loosely correlated
+0.56%
RVTY - BLFS
50%
Loosely correlated
+0.99%
TWST - BLFS
49%
Loosely correlated
+1.43%
AZTA - BLFS
49%
Loosely correlated
+2.07%
More